Previous metabolic flux studies, combined with isotope tracing, revealed that ASNS-deficient SCLC cells lose the ability to upregulate alternative anabolic routes and show increased sensitivity to glutamine withdrawal and hypoxia, supporting the theory that ASNS is the “keystone enzyme” for metabolic adaptation in SCLC [37]. Here, ASNS is linked to small cell lung carcinoma.